Lisa Colleran Not to Stand for Reelection as Director of Rockwell Medical, Inc
April 21, 2020 at 01:59 am IST
Share
Rockwell Medical, Inc. announced that on April 17, 2020, Stuart Paul resigned as the President and Chief Executive Officer of the company and as a member of the board of directors of the company effective immediately. As a result of Mr. Paul’s resignation and the previously disclosed decision by Lisa Colleran not to stand for reelection at the company’s 2020 Annual Meeting of Stockholders, the size of the Board will be reduced to five directors effective as of the Annual Meeting.
Rockwell Medical, Inc. is a healthcare company. The Company develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products for dialysis providers around the world. The Company operates in the hemodialysis market, which involves the manufacture, sale and distribution of hemodialysis products to hemodialysis clinics, including pharmaceuticals, dialysis concentrates, dialysis kits and other ancillary products used in the dialysis process. It is the supplier of life-sustaining hemodialysis concentrates products to dialysis clinics. Its hemodialysis concentrates products are used to sustain a patient's life by removing toxins and balancing electrolytes in a dialysis patientâs bloodstream. The Company manufactures hemodialysis concentrates at its facilities in Michigan, South Carolina, and Texas, and the Company manufactures its dry acid concentrate mixers at its facility in Iowa.